Edwards Lifesciences Corporation Restructuring Charges
Edwards Lifesciences Corporation (EW) reported Restructuring Charges of $13.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-02-25
- Edwards Lifesciences Corporation restructuring charges for the quarter ending 2025-12-31 was $4.60M.
- Edwards Lifesciences Corporation restructuring charges for the quarter ending 2025-09-30 was $100.00K, a 99.70% decline year-over-year.
- Edwards Lifesciences Corporation restructuring charges for the quarter ending 2024-12-31 was $0.00.
- Edwards Lifesciences Corporation restructuring charges for the quarter ending 2024-09-30 was $32.90M.
- Edwards Lifesciences Corporation restructuring charges for fiscal 2025 was $13.10M, a 60.18% decline from fiscal 2024.
- Edwards Lifesciences Corporation restructuring charges for fiscal 2024 was $32.90M.
- Edwards Lifesciences Corporation restructuring charges for fiscal 2015 was $0.00.
- Edwards Lifesciences Corporation restructuring charges for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
| Period end | Restructuring Charges 1 month | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $4.70M derived: sum of 2 quarters · filed 2026-02-25 | $13.10M 10-K · filed 2026-02-25 | ||
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-05 | $8.50M 10-Q · filed 2025-11-05 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $32.90M derived: sum of 2 quarters · filed 2026-02-25 | $32.90M 10-K · filed 2026-02-25 | ||
| 2024-09-30 | $32.90M 10-Q · filed 2024-11-06 | $32.90M 10-Q · filed 2025-11-05 | $32.90M 10-Q · filed 2025-11-05 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | |||
| 2018-09-30 | $0.00 10-Q · filed 2018-10-26 | $0.00 10-Q · filed 2018-10-26 | |||
| 2017-09-30 | $9.70M 10-Q · filed 2018-10-26 | $9.70M 10-Q · filed 2018-10-26 | |||
| 2015-12-31 | $0.00 10-K · filed 2016-02-19 | ||||
| 2014-12-31 | $0.00 10-K · filed 2016-02-19 | ||||
| 2013-12-31 | $10.40M 10-K · filed 2016-02-19 | ||||
| 2012-12-31 | $9.00M 10-K · filed 2015-02-20 | ||||
| 2011-12-31 | $5.50M 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |